These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 28346732

  • 21. Downregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: potential therapeutic use in the chemoprevention of keloids.
    Cho JW, Il KJ, Lee KS.
    Int J Mol Med; 2013 May; 31(5):1148-52. PubMed ID: 23503720
    [Abstract] [Full Text] [Related]

  • 22. Knockdown of IRF3 inhibits extracellular matrix expression in keloid fibroblasts.
    Zhang Y, Zhang L, Lin XH, Li ZM, Zhang QY.
    Biomed Pharmacother; 2017 Apr; 88():1064-1068. PubMed ID: 28192879
    [Abstract] [Full Text] [Related]

  • 23. Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF‑β/Smad and ERK signaling pathways.
    Tang M, Bian W, Cheng L, Zhang L, Jin R, Wang W, Zhang Y.
    Int J Mol Med; 2018 Mar; 41(3):1487-1499. PubMed ID: 29328420
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. LINC01116 regulates proliferation, migration, and apoptosis of keloid fibroblasts by the TGF-β1/SMAD3 signaling via targeting miR-3141.
    Wu D, Zhou J, Tan M, Zhou Y.
    Anal Biochem; 2021 Aug 15; 627():114249. PubMed ID: 34048784
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Keloid Core Factor CTRP3 Overexpression Significantly Controlled TGF-β1-Induced Propagation and Migration in Keloid Fibroblasts.
    He L, Zhu C, Dou H, Yu X, Jia J, Shu M.
    Dis Markers; 2023 Aug 15; 2023():9638322. PubMed ID: 37091895
    [Abstract] [Full Text] [Related]

  • 30. TMEM88 inhibits extracellular matrix expression in keloid fibroblasts.
    Zhao H, Lu F, Cui S, Zhang X, Wang W, Si E, Yuan Z.
    Biomed Pharmacother; 2017 Nov 15; 95():1436-1440. PubMed ID: 28946191
    [Abstract] [Full Text] [Related]

  • 31. Calcimycin Suppresses S100A4 Expression and Inhibits the Stimulatory Effect of Transforming Growth Factor β1 on Keloid Fibroblasts.
    Zhao YX, Ho CK, Xie Y, Chen YH, Li HZ, Zhang GY, Li QF.
    Ann Plast Surg; 2018 Aug 15; 81(2):163-169. PubMed ID: 29846215
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Syndecan-1 regulates extracellular matrix expression in keloid fibroblasts via TGF-β1/Smad and MAPK signaling pathways.
    Cui J, Jin S, Jin C, Jin Z.
    Life Sci; 2020 Aug 01; 254():117326. PubMed ID: 31954164
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Role of caveolin-1 in the pathogenesis of tissue fibrosis by keloid-derived fibroblasts in vitro.
    Zhang GY, Yu Q, Cheng T, Liao T, Nie CL, Wang AY, Zheng X, Xie XG, Albers AE, Gao WY.
    Br J Dermatol; 2011 Mar 01; 164(3):623-7. PubMed ID: 21375514
    [Abstract] [Full Text] [Related]

  • 39. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
    Tsujita-Kyutoku M, Uehara N, Matsuoka Y, Kyutoku S, Ogawa Y, Tsubura A.
    In Vivo; 2005 Mar 01; 19(6):959-63. PubMed ID: 16277007
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.